Results 1 to 10 of about 85,639 (150)

[A Case Report of Successful Control of Refractory Tumor Fever 
in Lung Adenocarcinoma with Interleukin-6 Antibody Tocilizumab]. [PDF]

Zhongguo Fei Ai Za Zhi
Li Y, Li C, Li B.
europepmc   +1 more source

[A Case of Endometrial Metastasis in Lung Adenocarcinoma 
after EGFR-TKIs Treatment Failure and Literature Review]. [PDF]

Zhongguo Fei Ai Za Zhi
Shen F, Hu Z, Yang H, Liu P, Bai Y, Zhou J, Ma H.   +6 more
europepmc   +1 more source

P53、SOX2、GAGE-7联合人工智能量化参数构建列线图模型预测浸润性肺腺癌病理分级

Zhongguo shiyan zhenduanxue
目的探讨基于肺癌自身抗体谱和人工智能（AI）量化参数的列线图模型在预测浸润性肺腺癌（IAC）病理分级中的临床应用价值。方法回顾性收集2023年9月至2024年11月于山东大学附属省立医院术后病理诊断为浸润性肺腺癌患者238例，依据2021年WHO新分类肺腺癌病理分级标准，将其分为Ⅲ级IAC组58例，非Ⅲ级IAC组180例。比较两组间参数差异，采用多因素logistic回归筛选IAC预后分级的独立预测因素并构建Ⅲ级IAC预测模型，并进行内部验证以评估其效能，用列线图进行可视化描述。结果(1 ...
范嘉铭, 许林, 尹诗, 肖晗, 付义林, 李鑫运, 王功朝   +6 more
doaj  

[Lung Adenocarcinoma with EGFR Exon 20 H773_V774delinsLM Mutation 
Sensitive to Furmonertinib: A Case Report]. [PDF]

Zhongguo Fei Ai Za Zhi
Li R, Xu Y, Gao X, Chen M, Zhong W, Wang M.   +5 more
europepmc   +1 more source

[Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis 
in Lung Adenocarcinoma Cells]. [PDF]

Zhongguo Fei Ai Za Zhi, 2023
Liu L, Guan X, Zhao Y, Wang X, Yin C, Liu Q, Li H.   +6 more
europepmc   +1 more source

[miR-2110 Affects the Biological Behaviors of Lung Adenocarcinoma by Regulating CDT1]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Mi Y, Li X, Wang C, Lin C, Zhao Z, Yan X, Shi P, Wang L.   +7 more
europepmc   +1 more source

[Exploring the Role of DKK1 in the Occurrence of Lung Adenocarcinoma Based on the Analysis of Bioinformatics]. [PDF]

Zhongguo Fei Ai Za Zhi, 2023
Lu R, Li Y, Xieyidai A, Yu T, Feng Y.
europepmc   +1 more source

肺腺癌及区域淋巴结18F-FDG PET/CT表现与血清CEA的相关性研究

Zhongshan Daxue xuebao. Yixue kexue ban, 2012
【目的】 探讨肺腺癌及区域淋巴结PET/CT表现与肿瘤标志物癌胚抗原CEA之间的关系,进一步提高肺癌诊断的准确性?【方法】 收集71例初诊的肺腺癌患者治疗前的PET/CT资料及同期外周静脉血CEA的结果?分析入选患者肺原发灶SUVmax?分化程度?原发灶大小?转移性淋巴结SUVmax?淋巴结N分期与血清CEA之间的关系?【结果】 肺原发灶SUVmax?大小与血清CEA呈正相关(P < 0.05)?淋巴结N分期情况与血清CEA有相关性,N0 ~ N3之间的差异有统计学意义(P < 0.05 ...
doaj  

[Application Value of Neoadjuvant Targeted Therapy in Patients with EGFR-mutant 
Resectable Lung Adenocarcinoma]. [PDF]

Zhongguo Fei Ai Za Zhi
Huang S, Fan M, Peng K, Yan W, Chen B, Wang W, Yang T, Chen K, Kang M, Xie J.   +9 more
europepmc   +1 more source

[Public Database-based Study to Explore the Expression and Role of DDB1 
in Lung Adenocarcinoma]. [PDF]

Zhongguo Fei Ai Za Zhi
Zou X, He Z, Zhang Y, Hu Y, Wang X, Wu Z.   +5 more
europepmc   +1 more source